Posted by herpills on September 6, 2012, at 21:11:30
Wed Aug 29, 2012 8:16am EDT
Aug 29 (Reuters) - Eli Lilly and Co said it would stop developing an experimental schizophrenia drug after a recent analysis showed that a late-stage trial on the drug was likely to fail.
Lilly said that an independent futility analysis concluded the second late-stage study on the drug was unlikely to meet the main goal of the trial.
Additionally, another mid-stage trial, which was testing the drug -- pomaglumetad methionil, or mGlu2/3 -- as an adjunctive treatment with atypical antipsychotics, also failed to meet the main study goal.
poster:herpills
thread:1025025
URL: http://www.dr-bob.org/babble/20120830/msgs/1025025.html